Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Organon Pharma Indonesia Tbk. (SCPI) vs Tunas Alfin Tbk. (TALF) Price & Performance

Organon Pharma Indonesia Tbk.Trade
Tunas Alfin Tbk.Trade

Price performance (Past 24H)

Key statistics

Organon Pharma Indonesia Tbk. vs Tunas Alfin Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Tunas Alfin Tbk. trades at Rp710 (market cap 927.1B, 392.7K 24h volume). The key difference: Tunas Alfin Tbk. is far larger — about 8.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

SCPITALF
Market Cap
104.4B927.1B
Volume
392.7K
Lot
3.93K
Turnover
279.69M
Average Price
712.23
Value
279.69M
Indicative Equilibrium Price
710
Indicative Equilibrium Volume
5

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SCPI
View details
TALF
View details

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI

About Tunas Alfin Tbk.

PT Tunas Alfin Tbk (the Company) was founded in 1977 and is based in Jakarta, Indonesia. With one of the largest production capacities, and some of the most advanced equipment and technologies in the region, the Company has also grown into one of the leading integrated fine and Fast Moving Consumer Goods (FMCG) packaging companies in Asia.The Company is currently capable of undertaking several coating processes such as Silicone, Hot Melt, Extrusion, Pressure/Self-Adhesive, Wax Coating and Anti-fungus Coating.

Read more on TALF